Show simple item record

dc.contributor.authorMijušković, M
dc.contributor.authorChou, Y-F
dc.contributor.authorGigi, V
dc.contributor.authorLindsay, CR
dc.contributor.authorShestova, O
dc.contributor.authorLewis, SM
dc.contributor.authorRoth, DB
dc.date.accessioned2018-06-13T08:16:37Z
dc.date.issued2015-09-01
dc.identifierhttp://www.sciencedirect.com/science/article/pii/S2211124715009195
dc.identifier.citationCell Reports, 2015, 12 (11), pp. 1842 - 1852
dc.identifier.issn2211-1247
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1846
dc.description.abstractGenome-wide analysis of thymic lymphomas from Tp53(-/-) mice with wild-type or C-terminally truncated Rag2 revealed numerous off-target, RAG-mediated DNA rearrangements. A significantly higher fraction of these errors mutated known and suspected oncogenes/tumor suppressor genes than did sporadic rearrangements (p < 0.0001). This tractable mouse model recapitulates recent findings in human pre-B ALL and allows comparison of wild-type and mutant RAG2. Recurrent, RAG-mediated deletions affected Notch1, Pten, Ikzf1, Jak1, Phlda1, Trat1, and Agpat9. Rag2 truncation substantially increased the frequency of off-target V(D)J recombination. The data suggest that interactions between Rag2 and a specific chromatin modification, H3K4me3, support V(D)J recombination fidelity. Oncogenic effects of off-target rearrangements created by this highly regulated recombinase may need to be considered in design of site-specific nucleases engineered for genome modification.
dc.format.extent1842 - 1852
dc.languageeng
dc.language.isoeng
dc.publisherElsevier BV
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectacute lymphoblastic-leukemia suppresses genomic instability mediated recombination notch1 gene in-vivo t-all activation mutations deletion jak1 Cell Biology
dc.titleOff-Target V(D)J Recombination Drives Lymphomagenesis and Is Escalated by Loss of the Rag2 C Terminus
dc.typeJournal Article
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2015-09
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfCell Reports
pubs.issue11
pubs.notesISI Document Delivery No.: CR8PX Times Cited: 0 Cited Reference Count: 28 Mijuskovic, Martina Chou, Yi-Fan Gigi, Vered Lindsay, Cory R. Shestova, Olga Lewis, Susanna M. Roth, David B. Nih [ca-104588, pn1ey018244, 1r21ai097825-01] Funding: NIH grants CA-104588 and PN1EY018244 to D.B.R. and 1R21AI097825-01 to S.M.L. We thank Ellen Rothenberg (Caltech), and David Schatz (Yale University) for making alternatively formatted data available for analysis. SRA: SRP043567. 0 Cell press Cambridge
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics
pubs.volume12
pubs.embargo.termsNot known
icr.researchteamOncogenetics
dc.contributor.icrauthorMijuskovic, Martina


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0